Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Reproductive Health Environment topic
No spam. Unsubscribe anytime.
Deeply divided committee advances bill targeting disposal of chemical‑abortion waste; opponents call it a barrier to care
Summary
Senate Bill 4-79 seeks to require manufacturers and providers to account for disposal of drugs and tissue from medication abortions and to treat discarded abortion materials as medical waste. Backers said the measure protects waterways; opponents said it criminalizes care, conflicts with Montana constitutional protections and would harm patients.
Senate Bill 4-79, introduced by Sen. Theresa Manzella, advanced from the Senate Judiciary Committee after hours of emotional testimony. The bill would impose disposal requirements and penalties related to pharmaceuticals used in medication abortion (mifepristone and misoprostol) and would require disposal protocols similar to those applied to medical waste; sponsors proposed funding manufacturer remediation and holding manufacturers responsible if their products entered wastewater in harmful concentrations.
Why it matters: Supporters framed the bill as an environmental‑protection measure, arguing that abortion pills and the tissue resulting from medication abortions contain endocrine‑disrupting compounds that can persist in wastewater and harm aquatic life and possibly human health. They asked the state to treat the resulting material as regulated medical waste and to require manufacturers to fund disposal and remediation.
Testimony and debate: Proponents included anti‑abortion organizations, property‑rights and conservative groups and several self‑identified citizens who spoke about environmental and moral concerns. Multiple opponents — Planned Parenthood Advocates Montana, Legal Voice, physicians and statewide medical organizations, the ACLU of Montana and clinicians — argued the bill is not grounded in accepted science, would create a chilling legal environment for providers, and would criminalize routine obstetric medications used for miscarriage care, postpartum hemorrhage and labor induction.
Opponents also noted the bill as written singled out abortion‑related medications while excluding other pharmaceutical contaminants; doctors testified those same medicines are used in non‑abortion care and that criminal penalties would deter standard medical practice and endanger patient safety.
Committee action and next steps: Despite vocal opposition and a legal review note on constitutional concerns, the committee voted to advance the bill; some senators cited Montana’s constitutional guarantee of a clean and healthful environment as justification for action. Supporters said they would press the measure on the Senate floor; opponents signaled plans to challenge the statute if enacted.
Ending: The measure is highly contentious and — if enacted — expected to prompt legal challenges and immediate debate on how environmental regulation intersects with reproductive‑health law and medical practice.
